Sort
48,018 grants matching “immunotherapy”
Immune Exclusion in Cancer Immunotherapy
$592,843Riyue Bao · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DE
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
$592,709Cristian T Badea · Duke University · U24 · FY2017 · CA
Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay
$592,674Yun Wu · State University Of New York At Buffalo · R01 · FY2022 · CA
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
$592,644Johannes Zakrzewski · Hackensack University Medical Center · R37 · FY2022 · CA
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
$592,593Lance L Munn · Massachusetts General Hospital · U01 · FY2024 · CA
Molecular Immunology and Tumor Biology
$592,571David Michael Langenau · Massachusetts General Hospital · T32 · FY2025 · CA
Dissecting high-risk cell states in neuroblastoma
$592,554Adam David Durbin · St. Jude Children'S Research Hospital · R37 · FY2025 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation
$592,532Cheryl A London · Tufts University Boston · U01 · FY2025 · CA
Design-driven engineering of robust mammalian sense-and-respond functions: from parts to programs
$592,483Joshua Nathaniel Leonard · Northwestern University · R01 · FY2025 · EB
RP-3: Elucidating Mechanisms of Sensitivity and Resistance to Checkpoint Blockade Therapy for Rational Multi-Drug Immunotherapy in Urothelial Cancers
$592,269Jonathan Eric Rosenberg · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancer
$592,252Mehmet Toner · Massachusetts General Hospital · U01 · FY2023 · CA
Mechanisms of Antigen-Induced Tolerance in the Lung
$592,242Anuradha Ray · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Cell type-directed Tim-3 targeting in melanoma
$592,227Steven Russell Barthel · Brigham And Women'S Hospital · R01 · FY2022 · CA
Exploring CD38 molecular biology and imaging in multiple myeloma pathogenesis
$592,217Monica Shokeen · Washington University · R01 · FY2024 · CA
Bioprinting Plant Virus Nanoparticles for Immunotherapy and Relapse Prevention of Ovarian Cancer
$592,114Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2020 · CA
Identifying and targeting neoantigens in aggressive salivary carcinomas
$592,082Luc Gordon Trang Morris · Sloan-Kettering Inst Can Research · R01 · FY2019 · DE
Linking insertional mutagenesis and cell function to improve CAR T cell therapy
$592,071Frederic D Bushman · University Of Pennsylvania · R01 · FY2023 · CA
Dendritic Cell mediated induction of Anti-HCV immunity
$592,049New York University School Of Medicine · R01 · FY2004 · AI
The Intersection of Sex, Innate Immunity and the HIV Reservoir
$592,037Nancie Marie Archin · Univ Of North Carolina Chapel Hill · R56 · FY2022 · AI
Clinical protocols for the treatment of gastrointestinal cancer
$591,982Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
$591,868Farrokh Dehdashti · Washington University · R01 · FY2022 · CA
Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
$591,863Katerina Abigail Politi · Yale University · R01 · FY2016 · CA
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesis
$591,768Andrea Schietinger · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA
Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer
$591,765Harry H Yoon · Mayo Clinic Rochester · R01 · FY2024 · CA
Regulators of Cancer Immunotherapy Response
$591,752Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2020 · CA